Welcome to the Future of Personalized Medicine for Mental Illness
with Dr. Riyad Domingo
Newly appointed Chief Innovation Officer of M2Bio Sciences, Dr Riyad Domingo, will be presenting his inaugural webinar on the future of mental health therapeutics derived from the psychedelic prodrug psilocybin.
He will provide an overview of the company's innovative work leveraging the power of artificial intelligence and additive manufacturing in the drug discovery and development process.
Welcome to the future of personalized medicine for mental illness.